市場調查報告書

藥物研發資訊學 : 市場機會分析及未來預測

Global Drug Discovery Informatics Market Size study, By Function, By Solutions, By End-users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations and other end-users) and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 888144
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
藥物研發資訊學 : 市場機會分析及未來預測 Global Drug Discovery Informatics Market Size study, By Function, By Solutions, By End-users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations and other end-users) and Regional Forecasts 2019-2026
出版日期: 2019年04月01日內容資訊: 英文
簡介

全球藥物研發資訊學市場2018年是18億9,000萬美金。今後在2019年∼2026年間,預測將以11.20%多的年複合成長率擴大。

本報告提供藥物研發資訊學的世界市場調查,市場概要,各類型、終端用戶、用途、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 主要的趨勢
  • 全球的及各分類市場預測,2016年-2026年(百萬美元)
    • 各功能,2016年-2026年(百萬美元)
    • 各解決方案,2016年-2026年(百萬美元)
    • 各終端用戶,2016年-2026年(百萬美元)
    • 各地區,2016年-2026年(百萬美元)
  • 預測方法
  • 調查的前提條件

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 產業的演進
    • 調查範圍
  • 調查期間
  • 貨幣換算比率

第3章 市場動態

  • Seesaw分析
    • 成長要素
    • 市場課題
    • 市場機會

第4章 市場產業分析

  • 五力分析模型
    • 買方議價能力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭情形
    • 對五力分析模型的未來方法
  • PEST分析
    • 政治方案
    • 經濟方案
    • 社會方案
    • 技術方案
  • 主要的購買標準(按需)
  • 法律規範(按需)
  • 投資/引進方案(按需)
  • 分析師的建議與結論

第5章 藥物研發資訊學市場:各功能

  • 市場概述
  • 市場效能 - 潛在模式
  • 子區隔分析
    • 序列測定及標的資料分析
    • 對接
    • 分子模擬
    • 程序庫和資料庫的準備
    • 其他

第6章 藥物研發資訊學市場:各解決方案

  • 市場概述
  • 市場效能 - 潛在模式
  • 子區隔分析
    • 軟體
    • 服務

第7章 藥物研發資訊學市場:各終端用戶

  • 市場概述
  • 市場效能 - 潛在模式
  • 子區隔分析
    • 製藥及生物科技企業
    • 受託研究機構
    • 其他

第8章 藥物研發資訊學市場:各地區

  • 地區市場概述(2016-2026)
  • 北美市場概述
    • 美國
    • 加拿大
  • 歐洲市場概述
    • 英國
    • 德國
    • 其他
  • 亞洲市場概述
    • 中國
    • 印度
    • 日本
    • 其他
  • 中南美市場概述
    • 巴西
    • 墨西哥
  • 其他
    • 南美
    • 中東、非洲

第9章 競爭情形

  • 企業的市場佔有率(資料的各可得性)
  • 首位市場策略
  • 企業簡介
    • Jubilant Life Sciences
    • IBM
    • Infosys
    • Thermo Fisher Scientific
    • Perkinelmer
    • Schrodinger
    • Dassault Systemes
    • Charles River Laboratories
    • Selvita
    • GVK Biosciences

第10章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global Drug Discovery Informatics Market is valued approximately USD 1.89 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11.20% over the forecast period 2019-2026. Drug discovery informatics is a functional process performed by biotechnology and pharmaceutical companies that requires the generation of very large data and information. Through application of modern engineering and computational approaches the models are analyzed, visualized and simulated for pharmacological profiling. Further, rising R&D expenditure on pharmaceuticals along with the increasing government focus on drug discovery are some key forces, driving the growth of the drug discovery informatics market over the forecast period of 2019-2026. For instance: According to the U.K. government in 2016, drug development sector and continuous manufacturing would receive funds around USD 82.5 million from government and private sources as part of its new USD 188 million effort and 'Industry Strategy' to establish six key research hubs in UK to boost research and development activities related to drug discovery. As a result, the adoption of the drug discovery informatics would increase thereby, contributing towards the growth of the market. However, high pricing and set up cost of informatics software impede the growth of the global drug discover informatics market.

Major market player included in this report are:

  • Jubilant Life Sciences
  • IBM
  • Infosys
  • Thermo Fisher Scientific
  • Perkinelmer
  • Schrodinger
  • Dassault Systemes
  • Charles River Laboratories
  • GVK Biosciences
  • Boehringer Ingelheim GmbH

The regional analysis of global drug discovery informatics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-established healthcare infrastructure along with the presence of various biotechnology and drug companies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to availability of low cost of human resources and manufacturing and availability of many qualified researchers. Also, the growth of the Asia-Pacific region is attributed owing to the ongoing drug development activities undertaken by government.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Function:

  • Sequencing & Target Data Analysis
  • Docking
  • Molecular Modelling
  • Libraries & Database Preparation
  • Other Functions

By Solution:

  • Software
  • Services

By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROS)
  • Others End Users

By Regions:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Drug Discovery Informatics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
    • 1.3.1. Drug Discovery Informatics Market, by Function, 2016-2026 (USD Million)
    • 1.3.2. Drug Discovery Informatics Market, by Solution , 2016-2026 (USD Million)
    • 1.3.3. Drug Discovery Informatics Market, by End-user 2016-2026 (USD Million)
    • 1.3.4. Drug Discovery Informatics Market, by Region, 2016-2026 (USD Million)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Drug Discovery Informatics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Drug Discovery Informatics Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Drug Discovery Informatics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Discovery Informatics Market, by Function

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Drug Discovery Informatics Market, Sub Segment Analysis
    • 5.3.1. Sequencing & Target Data Analysis
      • 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.2. Docking
      • 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.3. Molecular Modelling
      • 5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.4. Libraries & Database Preparation
      • 5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.5. Other Functions
      • 5.3.5.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 6. Global Drug Discovery Informatics Market, by Solution

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Drug Discovery Informatics Market, Sub Segment Analysis
    • 6.3.1. Software
      • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 6.3.2. Services
      • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 7. Global Drug Discovery Informatics Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Drug Discovery Informatics Market, Sub Segment Analysis
    • 7.3.1. Pharmaceutical and Biotechnology Companies
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.3.2. Contract Research Organizations (CROS)
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.3.3. Others End Users
      • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 8. Global Drug Discovery Informatics Market, by Regional Analysis

  • 8.1. Drug Discovery Informatics Market, Regional Market Snapshot (2016-2026)
  • 8.2. North America Drug Discovery Informatics Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.2.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.2.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.2.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.2.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.2.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.2.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 8.3. Europe Drug Discovery Informatics Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.3.3. Rest of Europe
      • 8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.3.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.3.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.3.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 8.4. Asia Drug Discovery Informatics Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.3.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.3.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.4.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.4.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.4.4.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 8.5. Latin America Drug Discovery Informatics Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.5.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.5.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.5.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.5.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.5.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.5.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 8.6. Rest of The World
    • 8.6.1. South America
      • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.6.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.6.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.6.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 8.6.2. Middle East and Africa
      • 8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 8.6.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.6.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 8.6.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Jubilant Life Sciences
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Product Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. IBM
    • 9.3.3. Infosys
    • 9.3.4. Thermo Fisher Scientific
    • 9.3.5. Perkinelmer
    • 9.3.6. Schrodinger
    • 9.3.7. Dassault Systemes
    • 9.3.8. Charles River Laboratories
    • 9.3.9. Selvita
    • 9.3.10. GVK Biosciences

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
    • 10.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF DRUG DISCOVERY INFORMATICS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF DRUG DISCOVERY INFORMATICS MARKET
  • TABLE 3. DRUG DISCOVERY INFORMATICS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY FUNCTION 2016-2026 (USD BILLION)
  • TABLE 8. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SOLUTION 2016-2026 (USD BILLION)
  • TABLE 9. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY END-USERS 2016-2026 (USD BILLION)
  • TABLE 10. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. DRUG DISCOVERY INFORMATICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. U.S. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. U.S. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. U.S. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. U.S. DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. CANADA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52. CANADA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. CANADA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. CANADA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. UK DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. UK DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. UK DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. UK DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. GERMANY DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. ROE DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 67. ROE DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. ROE DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. ROE DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. CHINA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 72. CHINA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. CHINA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. CHINA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. INDIA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 77. INDIA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. INDIA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. INDIA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. JAPAN DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. ROAPAC DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. BRAZIL DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. MEXICO DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. ROLA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 102. ROLA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROLA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROLA DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROW DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 107. ROW DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 108. ROW DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 110. ROW DRUG DISCOVERY INFORMATICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. DRUG DISCOVERY INFORMATICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. DRUG DISCOVERY INFORMATICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. DRUG DISCOVERY INFORMATICS MARKET, KEY TRENDS 2017
  • FIG 5. DRUG DISCOVERY INFORMATICS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. DRUG DISCOVERY INFORMATICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. DRUG DISCOVERY INFORMATICS MARKET, PEST ANALYSIS
  • FIG 8. DRUG DISCOVERY INFORMATICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. DRUG DISCOVERY INFORMATICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. DRUG DISCOVERY INFORMATICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA DRUG DISCOVERY INFORMATICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 33. EUROPE DRUG DISCOVERY INFORMATICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 34. ASIA PACIFIC DRUG DISCOVERY INFORMATICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 35. LATIN AMERICA DRUG DISCOVERY INFORMATICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 36. DRUG DISCOVERY INFORMATICS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
Back to Top